바이오의약품 제3자 물류(3PL) 시장 규모, 점유율, 성장 분석, 공급망별, 서비스 유형별, 지역별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2025-2032년)

Global Biopharmaceuticals Third Party Logistics 3pl Market size was valued at USD 124.8 billion in 2023 and is poised to grow from USD 132.41 billion in 2024 to USD 212.64 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The biopharmaceutical third-party logistics (3PL) market is experiencing significant growth due to the rapid expansion of the pharmaceutical industry and a rising trend of medical organizations outsourcing logistics. 3PL providers play a crucial role in helping pharmaceutical companies manage warehouse operations, order fulfillment, and inventory control, ultimately optimizing transportation and reducing overhead costs. This shift allows companies to focus on enhancing their distribution networks amid strong sales figures and a surge in biosimilar launches. Additionally, the COVID-19 pandemic catalyzed innovation within the supply chain, as the demand for temperature-controlled packaging for vaccines highlighted the need for improved logistics solutions. With these trends, the outlook for the biopharmaceutical 3PL market remains positive, indicating robust opportunities for growth and efficiency enhancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Third Party Logistics 3Pl market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Third Party Logistics 3Pl Market Segmental Analysis

Global Biopharmaceuticals Third Party Logistics 3pl Market is segmented by Supply Chain, Service Type and region. Based on Supply Chain, the market is segmented into Cold Chain Logistics and Non-cold Chain Logistics. Based on Service Type, the market is segmented into Transportation, Warehousing and Storage and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Third Party Logistics 3Pl Market

The biopharmaceutical third-party logistics (3PL) market is experiencing robust growth, driven by the rising demand for efficient logistics solutions tailored for the safe transportation of temperature-sensitive medications. The surge in biologics and biosimilars, which necessitate stringent temperature-controlled logistics services, significantly contributes to this trend. Additionally, the increased integration of automation in manufacturing operations aims to reduce costs, consequently enhancing demand for 3PL services. Coupled with the growing prevalence of chronic diseases, which boosts the need for biologics, these factors collectively propel the expansion of the biopharmaceutical 3PL market, indicating a promising future ahead.

Restraints in the Global Biopharmaceuticals Third Party Logistics 3Pl Market

The global market for biopharmaceutical third-party logistics (3PL) faces significant challenges due to a shortage of skilled workers, particularly in developing regions where logistics service development is not keeping pace with that of developed countries. This scarcity of qualified personnel impairs the ability to meet the rising demand for logistics services and poses a barrier to the expansion of the biopharmaceutical 3PL sector. Consequently, the constraints hinder growth prospects and overall industry development, ultimately limiting the effectiveness and efficiency of logistics operations within the biopharmaceutical market during the forecast period.

Market Trends of the Global Biopharmaceuticals Third Party Logistics 3Pl Market

The Global Biopharmaceuticals Third Party Logistics (3PL) market is witnessing a robust trend towards enhanced value-added services, driven by significant investments in research and development. Companies are increasingly adopting smart sensor technology to monitor ambient conditions during transportation, ensuring the integrity of sensitive biopharmaceuticals. This technological advancement allows logistics providers like DHL to optimize their distribution networks, improve operational efficiency, and meet stringent regulatory demands. As the biopharmaceutical sector expands and diversifies, the reliance on specialized 3PL partners capable of delivering tailored logistic solutions is becoming paramount, fueling growth and innovation within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Third Party Logistics 3pl Market Size by Supply Chain & CAGR (2025-2032)

• Market Overview
• Cold Chain Logistics
• Non-cold Chain Logistics

Global Biopharmaceuticals Third Party Logistics 3pl Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing and Storage
• Other Services

Global Biopharmaceuticals Third Party Logistics 3pl Market Size & CAGR (2025-2032)

• North America (Supply Chain, Service Type)
  • US
  • Canada
• Europe (Supply Chain, Service Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Supply Chain, Service Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Supply Chain, Service Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Supply Chain, Service Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• DHL (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FedEx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Parcel Service (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuehne+Nagel (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DB Schenker (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agility (Kuwait)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EVERSANA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Logistics Network Limited (Hong Kong)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SF Express (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XPO Logistics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEVA Logistics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoport, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations